Tag: CAVT

forward study

First patient enrolled in Penumbra’s FORWARD study of mechanical thrombectomy for...

Penumbra has announced the initiation of its FORWARD study, an international, real-world, prospective, multicentre study, which will collect safety and efficacy data on mechanical...

Penumbra expands CAVT for stroke into Europe with Thunderbolt CE mark

Penumbra announced today that it has secured a CE mark in Europe for Thunderbolt, which the company says further lays the groundwork for computer-assisted...
penumbra thunderbolt

Computer-assisted vacuum thrombectomy arrives in stroke care with Thunderbolt US FDA...

Penumbra has announced it has received US Food and Drug Administration (FDA) clearance for Thunderbolt, expanding its computer-assisted vacuum thrombectomy (CAVT) technology into the world of...

Penumbra announces completion of enrolment in THUNDER IDE study

Penumbra has announced the completion of enrolment in its THUNDER investigational device exemption (IDE) clinical study for patients with acute ischaemic stroke. THUNDER is evaluating...